Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable
Executive Summary
Proposals to pay for an expansion of health care coverage that would directly affect pharmaceuticals took a backseat to tax-related options during the Senate Finance Committee's May 12 roundtable discussion on financing health care reform
You may also be interested in...
Obama Medicaid Rebate Provisions Make Way Into Finance Cmte. Options
The Senate Finance Committee is looking to the pharmaceutical industry to contribute to paying for health care reform in the form of adjustments to Medicaid rebates and the introduction of means testing in Medicare Part D
Obama Medicaid Rebate Provisions Make Way Into Finance Cmte. Options
The Senate Finance Committee is looking to the pharmaceutical industry to contribute to paying for health care reform in the form of adjustments to Medicaid rebates and the introduction of means testing in Medicare Part D
Insurers Remain Skeptical Of Public Plan As Sen. Schumer Rolls Out Proposal
Representatives of the insurance industry and big business remained skeptical about the feasibility and fairness of a public insurance option competing with private plans during a Senate Finance Committee roundtable discussion May 5